 | | HWF | | 表記: | (2S)-3-phenyl-2-[(3R)-pyrrolidin-3-yl]propanoic acid | | 組成式: | C13 H17 N O2 | | SMILES: | O=C(O)C(Cc1ccccc1)C1CCNC1 | | InChi: | InChI=1S/C13H17NO2/c15-13(16)12(11-6-7-14-9-11)8-10-4-2-1-3-5-10/h1-5,11-12,14H,6-9H2,(H,15,16)/t11-,12-/m0/s1 | | 別名: | LY3353871 | | 定義日: | 2023-07-22 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2S)-3-phenyl-2-[(3R)-pyrrolidin-3-yl]propanoic acid |
|
 | | TXJ | | 表記: | [(2S)-1-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-propan-2-yl]oxymethyl-[oxidanyl(phosphonooxy)phosphoryl]oxy-phosphinic acid | | 組成式: | C8 H16 N3 O12 P3 | | SMILES: | NC1=NC(=O)N(C[CH](CO)OC[P](O)(=O)O[P](O)(=O)O[P](O)(O)=O)C=C1 | | InChi: | InChI=1S/C8H16N3O12P3/c9-7-1-2-11(8(13)10-7)3-6(4-12)21-5-24(14,15)22-26(19,20)23-25(16,17)18/h1-2,6,12H,3-5H2,(H,14,15)(H,19,20)(H2,9,10,13)(H2,16,17,18)/t6-/m0/s1 | | 定義日: | 2023-05-10 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | [(2~{S})-1-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-propan-2-yl]oxymethyl-[oxidanyl(phosphonooxy)phosphoryl]oxy-phosphinic acid |
|
 | | ZP2 | | 表記: | (3-fluoranyl-5-oxidanyl-phenyl)-(3-methoxy-5-nitro-4-oxidanyl-phenyl)methanone | | 組成式: | C14 H10 F N O6 | | SMILES: | COc1cc(cc(c1O)[N+]([O-])=O)C(=O)c2cc(O)cc(F)c2 | | InChi: | InChI=1S/C14H10FNO6/c1-22-12-5-8(4-11(14(12)19)16(20)21)13(18)7-2-9(15)6-10(17)3-7/h2-6,17,19H,1H3 | | 別名: | Pharmacokinetically Improved TTR Binder (PITB) | | 定義日: | 2023-06-29 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (3-fluoranyl-5-oxidanyl-phenyl)-(3-methoxy-5-nitro-4-oxidanyl-phenyl)methanone |
|
 | | Y2W | | 表記: | [(1~{S},2~{R},3~{R},4~{S},6~{R})-6-azanyl-2,3,4-tris(oxidanyl)cyclohexyl]methanesulfonic acid | | 組成式: | C7 H15 N O6 S | | SMILES: | N[CH]1C[CH](O)[CH](O)[CH](O)[CH]1C[S](O)(=O)=O | | InChi: | InChI=1S/C7H15NO6S/c8-4-1-5(9)7(11)6(10)3(4)2-15(12,13)14/h3-7,9-11H,1-2,8H2,(H,12,13,14)/t3-,4+,5-,6+,7+/m0/s1 | | 定義日: | 2023-11-16 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | [(1~{S},2~{R},3~{R},4~{S},6~{R})-6-azanyl-2,3,4-tris(oxidanyl)cyclohexyl]methanesulfonic acid |
|
 | | W4X | | 表記: | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid | | 組成式: | C22 H15 N O5 | | SMILES: | OC(=O)C(=O)c1cn(c2ccc(O)c(O)c2)c3ccc(cc13)c4ccccc4 | | InChi: | InChI=1S/C22H15NO5/c24-19-9-7-15(11-20(19)25)23-12-17(21(26)22(27)28)16-10-14(6-8-18(16)23)13-4-2-1-3-5-13/h1-12,24-25H,(H,27,28) | | 定義日: | 2023-04-28 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid |
|
 | | W52 | | 表記: | 2-[1-(4-hydroxyphenyl)-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid | | 組成式: | C22 H15 N O4 | | SMILES: | Oc1ccc(cc1)n2cc(C(=O)C(O)=O)c3cc(ccc23)c4ccccc4 | | InChi: | InChI=1S/C22H15NO4/c24-17-9-7-16(8-10-17)23-13-19(21(25)22(26)27)18-12-15(6-11-20(18)23)14-4-2-1-3-5-14/h1-13,24H,(H,26,27) | | 定義日: | 2023-04-28 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 2-[1-(4-hydroxyphenyl)-5-phenyl-indol-3-yl]-2-oxidanylidene-ethanoic acid |
|
 | | W5E | | 表記: | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-(3-hydroxyphenyl)indol-3-yl]-2-oxidanylidene-ethanoic acid | | 組成式: | C22 H15 N O6 | | SMILES: | Oc1cccc(c1)c2ccc3n(cc(C(=O)C(O)=O)c3c2)c4ccc(O)c(O)c4 | | InChi: | InChI=1S/C22H15NO6/c24-15-3-1-2-12(8-15)13-4-6-18-16(9-13)17(21(27)22(28)29)11-23(18)14-5-7-19(25)20(26)10-14/h1-11,24-26H,(H,28,29) | | 定義日: | 2023-04-28 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 2-[1-[3,4-bis(oxidanyl)phenyl]-5-(3-hydroxyphenyl)indol-3-yl]-2-oxidanylidene-ethanoic acid |
|
 | | VPN | | 表記: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate | | 組成式: | C45 H83 Br4 O13 P | | SMILES: | OP(=O)(OC1C(O)C(O)C(O)C(O)C1O)OCC(COC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC)OC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC | | InChi: | InChI=1S/C45H83Br4O13P/c1-3-5-7-9-13-19-25-34(46)36(48)27-21-15-11-17-23-29-38(50)59-31-33(32-60-63(57,58)62-45-43(55)41(53)40(52)42(54)44(45)56)61-39(51)30-24-18-12-16-22-28-37(49)35(47)26-20-14-10-8-6-4-2/h33-37,40-45,52-56H,3-32H2,1-2H3,(H,57,58)/t33-,34-,35?,36+,37?,40-,41-,42+,43+,44+,45-/m0/s1 | | 定義日: | 2023-09-15 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate |
|
 | | JEI | | 表記: | (3-{(2S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2-phosphonoethoxy)methyl]pyrrolidin-1-yl}-3-oxopropyl)phosphonic acid | | 組成式: | C15 H24 N6 O9 P2 | | SMILES: | O=C(CCP(=O)(O)O)N1CC(CC1COCCP(=O)(O)O)n1cnc2c1N=C(N)NC2=O | | InChi: | InChI=1S/C15H24N6O9P2/c16-15-18-13-12(14(23)19-15)17-8-21(13)9-5-10(7-30-2-4-32(27,28)29)20(6-9)11(22)1-3-31(24,25)26/h8-10H,1-7H2,(H2,24,25,26)(H2,27,28,29)(H3,16,18,19,23)/t9-,10+/m1/s1 | | 定義日: | 2023-08-07 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (3-{(2S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2-phosphonoethoxy)methyl]pyrrolidin-1-yl}-3-oxopropyl)phosphonic acid |
|
 | | Y6Z | | 表記: | Antascomicine B | | 組成式: | C37 H57 N O10 | | SMILES: | C[CH]1CC[CH](OC(=O)[CH]2CCCCN2C(=O)C(=O)[C]3(O)O[CH](CC[CH]3C)[CH](C)C(=O)C=CCCC=C1)[CH](C)C[CH]4CC[CH](O)[CH](O)[CH]4O | | InChi: | InChI=1S/C37H57NO10/c1-22-11-7-5-6-8-13-28(39)25(4)31-19-15-24(3)37(46,48-31)34(43)35(44)38-20-10-9-12-27(38)36(45)47-30(18-14-22)23(2)21-26-16-17-29(40)33(42)32(26)41/h7-8,11,13,22-27,29-33,40-42,46H,5-6,9-10,12,14-21H2,1-4H3/b11-7+,13-8+/t22-,23+,24+,25-,26-,27-,29+,30-,31-,32-,33-,37+/m0/s1 | | 別名: | (1R,9S,12S,15S,16E,20E,23R,24S,27R)-1-Hydroxy-15,23,27-trimethyl-12-{(2R)-1-[(1S,2S,3S,4R)-2,3,4-trihydroxycyclohexyl]-2-propanyl}-11,28-dioxa-4-azatricyclo[22.3.1.0~4,9~]octacosa-16,20-diene-2,3,10,22-tetrone | | 定義日: | 2023-11-23 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (1~{R},9~{S},12~{S},15~{R},16~{E},20~{E},23~{R},24~{S},27~{R})-15,23,27-trimethyl-1-oxidanyl-12-[(2~{R})-1-[(1~{S},2~{S},3~{S},4~{R})-2,3,4-tris(oxidanyl)cyclohexyl]propan-2-yl]-11,28-dioxa-4-azatricyclo[22.3.1.0^{4,9}]octacosa-16,20-diene-2,3,10,22-tetrone |
|
 | | JG6 | | 表記: | {3-[(2S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-oxopropyl}phosphonic acid | | 組成式: | C13 H19 N6 O6 P | | SMILES: | O=C(CCP(=O)(O)O)N1CC(CC1CO)n1cnc2c1N=C(N)NC2=O | | InChi: | InChI=1S/C13H19N6O6P/c14-13-16-11-10(12(22)17-13)15-6-19(11)7-3-8(5-20)18(4-7)9(21)1-2-26(23,24)25/h6-8,20H,1-5H2,(H2,23,24,25)(H3,14,16,17,22)/t7-,8+/m1/s1 | | 定義日: | 2023-08-07 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | {3-[(2S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-oxopropyl}phosphonic acid |
|
 | | WCW | | 表記: | 4-azanyl-1-phenyl-piperidine-4-carboxylic acid | | 組成式: | C12 H16 N2 O2 | | SMILES: | NC1(CCN(CC1)c2ccccc2)C(O)=O | | InChi: | InChI=1S/C12H16N2O2/c13-12(11(15)16)6-8-14(9-7-12)10-4-2-1-3-5-10/h1-5H,6-9,13H2,(H,15,16) | | 定義日: | 2023-05-12 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 4-azanyl-1-phenyl-piperidine-4-carboxylic acid |
|
 | | WD2 | | 表記: | 1-[4-(trifluoromethyl)pyridin-2-yl]piperazine | | 組成式: | C10 H12 F3 N3 | | SMILES: | FC(F)(F)c1ccnc(c1)N2CCNCC2 | | InChi: | InChI=1S/C10H12F3N3/c11-10(12,13)8-1-2-15-9(7-8)16-5-3-14-4-6-16/h1-2,7,14H,3-6H2 | | 定義日: | 2023-05-12 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 1-[4-(trifluoromethyl)pyridin-2-yl]piperazine |
|
 | | WD5 | | 表記: | 4-(4-chlorophenyl)piperidin-4-ol | | 組成式: | C11 H14 Cl N O | | SMILES: | OC1(CCNCC1)c2ccc(Cl)cc2 | | InChi: | InChI=1S/C11H14ClNO/c12-10-3-1-9(2-4-10)11(14)5-7-13-8-6-11/h1-4,13-14H,5-8H2 | | 定義日: | 2023-05-12 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 4-(4-chlorophenyl)piperidin-4-ol |
|
 | | KFF | | 表記: | (3-{(2S,4S)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2-phosphonoethoxy)methyl]pyrrolidin-1-yl}-3-oxopropyl)phosphonic acid | | 組成式: | C15 H24 N6 O9 P2 | | SMILES: | O=C(CCP(=O)(O)O)N1CC(CC1COCCP(=O)(O)O)n1cnc2c1N=C(N)NC2=O | | InChi: | InChI=1S/C15H24N6O9P2/c16-15-18-13-12(14(23)19-15)17-8-21(13)9-5-10(7-30-2-4-32(27,28)29)20(6-9)11(22)1-3-31(24,25)26/h8-10H,1-7H2,(H2,24,25,26)(H2,27,28,29)(H3,16,18,19,23)/t9-,10-/m0/s1 | | 定義日: | 2023-08-11 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (3-{(2S,4S)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-[(2-phosphonoethoxy)methyl]pyrrolidin-1-yl}-3-oxopropyl)phosphonic acid |
|
 | | V5H | | 表記: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate | | 組成式: | C45 H85 Br4 O19 P3 | | SMILES: | OP(=O)(O)OC1C(O)C(O)C(OP(=O)(O)OCC(COC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC)OC(=O)CCCCCCCC(Br)C(Br)CCCCCCCC)C(O)C1OP(=O)(O)O | | InChi: | InChI=1S/C45H85Br4O19P3/c1-3-5-7-9-13-19-25-34(46)36(48)27-21-15-11-17-23-29-38(50)63-31-33(65-39(51)30-24-18-12-16-22-28-37(49)35(47)26-20-14-10-8-6-4-2)32-64-71(61,62)68-43-40(52)41(53)44(66-69(55,56)57)45(42(43)54)67-70(58,59)60/h33-37,40-45,52-54H,3-32H2,1-2H3,(H,61,62)(H2,55,56,57)(H2,58,59,60)/t33-,34-,35?,36+,37?,40+,41-,42-,43+,44+,45+/m0/s1 | | 定義日: | 2023-09-08 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2S)-2-[(9,10-dibromooctadecanoyl)oxy]-3-{[(S)-hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propyl (9R,10S)-9,10-dibromooctadecanoate |
|
 | | WNO | | 表記: | 2-[(2~{R})-1-ethylimidazolidin-2-yl]-6-pyridin-2-yl-pyridine | | 組成式: | C15 H18 N4 | | SMILES: | CCN1CCN[CH]1c2cccc(n2)c3ccccn3 | | InChi: | InChI=1S/C15H18N4/c1-2-19-11-10-17-15(19)14-8-5-7-13(18-14)12-6-3-4-9-16-12/h3-9,15,17H,2,10-11H2,1H3/t15-/m1/s1 | | 定義日: | 2023-10-09 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 2-[(2~{R})-1-ethylimidazolidin-2-yl]-6-pyridin-2-yl-pyridine |
|
 | | LVC | | 表記: | 4-(2-oxopropyl)benzoic acid | | 組成式: | C10 H10 O3 | | SMILES: | O=C(C)Cc1ccc(cc1)C(=O)O | | InChi: | InChI=1S/C10H10O3/c1-7(11)6-8-2-4-9(5-3-8)10(12)13/h2-5H,6H2,1H3,(H,12,13) | | 定義日: | 2022-03-04 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 4-(2-oxopropyl)benzoic acid |
|
 | | LVK | | 表記: | 4-propanoylbenzoic acid | | 組成式: | C10 H10 O3 | | SMILES: | OC(=O)c1ccc(cc1)C(=O)CC | | InChi: | InChI=1S/C10H10O3/c1-2-9(11)7-3-5-8(6-4-7)10(12)13/h3-6H,2H2,1H3,(H,12,13) | | 定義日: | 2022-03-04 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 4-propanoylbenzoic acid |
|
 | | IJM | | 表記: | (6M)-3-hydroxy-4-oxo-6-[(4M)-4-(1H-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-2-carboxylic acid | | 組成式: | C14 H8 F3 N5 O4 | | SMILES: | O=C(O)C=1NC(=CC(=O)C=1O)c1ccc(cc1C(F)(F)F)c1nnn[NH]1 | | InChi: | InChI=1S/C14H8F3N5O4/c15-14(16,17)7-3-5(12-19-21-22-20-12)1-2-6(7)8-4-9(23)11(24)10(18-8)13(25)26/h1-4,24H,(H,18,23)(H,25,26)(H,19,20,21,22) | | 定義日: | 2023-08-01 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (6M)-3-hydroxy-4-oxo-6-[(4M)-4-(1H-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-2-carboxylic acid |
|
 | | F3L | | 表記: | 4-[(3~{S},4~{S})-4-(aminomethyl)-1-(5-chloranylpyridin-2-yl)sulfonyl-4-oxidanyl-pyrrolidin-3-yl]oxy-2-fluoranyl-benzenecarbonitrile | | 組成式: | C17 H16 Cl F N4 O4 S | | SMILES: | NC[C]1(O)CN(C[CH]1Oc2ccc(C#N)c(F)c2)[S](=O)(=O)c3ccc(Cl)cn3 | | InChi: | InChI=1S/C17H16ClFN4O4S/c18-12-2-4-16(22-7-12)28(25,26)23-8-15(17(24,9-21)10-23)27-13-3-1-11(6-20)14(19)5-13/h1-5,7,15,24H,8-10,21H2/t15-,17-/m0/s1 | | 別名: | 4-[(3S,4S)-4-(aminomethyl)-1-(5-chloropyridin-2-yl)sulfonyl-4-hydroxypyrrolidin-3-yl]oxy-2-fluorobenzonitrile | | 定義日: | 2023-06-27 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | 4-[(3~{S},4~{S})-4-(aminomethyl)-1-(5-chloranylpyridin-2-yl)sulfonyl-4-oxidanyl-pyrrolidin-3-yl]oxy-2-fluoranyl-benzenecarbonitrile |
|
 | | F8O | | 表記: | (2~{R},4~{R})-2,4-dimethyloctanal | | 組成式: | C10 H20 O | | SMILES: | CCCC[CH](C)C[CH](C)C=O | | InChi: | InChI=1S/C10H20O/c1-4-5-6-9(2)7-10(3)8-11/h8-10H,4-7H2,1-3H3/t9-,10-/m1/s1 | | 定義日: | 2023-07-19 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2~{R},4~{R})-2,4-dimethyloctanal |
|
 | | F9M | | 表記: | [6-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]pyridin-3-yl]-[(1~{S},5~{R})-3-[5-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone | | 組成式: | C25 H23 F3 N8 O S2 | | SMILES: | Cc1sc(c(C)n1)c2csc(Nc3ccc(cn3)C(=O)N4[CH]5CC[CH]4CN(C5)c6ncc(cn6)C(F)(F)F)n2 | | InChi: | InChI=1S/C25H23F3N8OS2/c1-13-21(39-14(2)32-13)19-12-38-24(33-19)34-20-6-3-15(7-29-20)22(37)36-17-4-5-18(36)11-35(10-17)23-30-8-16(9-31-23)25(26,27)28/h3,6-9,12,17-18H,4-5,10-11H2,1-2H3,(H,29,33,34)/t17-,18+ | | 定義日: | 2023-07-04 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | [6-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]amino]pyridin-3-yl]-[(1~{S},5~{R})-3-[5-(trifluoromethyl)pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone |
|
 | | FDO | | 表記: | (2~{R})-4-methyl-2-(methylamino)pentanamide | | 組成式: | C7 H16 N2 O | | SMILES: | CN[CH](CC(C)C)C(N)=O | | InChi: | InChI=1S/C7H16N2O/c1-5(2)4-6(9-3)7(8)10/h5-6,9H,4H2,1-3H3,(H2,8,10)/t6-/m1/s1 | | 定義日: | 2023-07-19 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2~{R})-4-methyl-2-(methylamino)pentanamide |
|
 | | FH6 | | 表記: | (2~{R})-2-azanyl-3-[(2~{S},3~{R})-2-methyl-5-oxidanylidene-pyrrolidin-3-yl]sulfanyl-propanal | | 組成式: | C8 H14 N2 O2 S | | SMILES: | C[CH]1NC(=O)C[CH]1SC[CH](N)C=O | | InChi: | InChI=1S/C8H14N2O2S/c1-5-7(2-8(12)10-5)13-4-6(9)3-11/h3,5-7H,2,4,9H2,1H3,(H,10,12)/t5-,6+,7+/m0/s1 | | 定義日: | 2023-07-19 | | 最終更新日: | 2024-05-03 | | 公開日: | 2024-05-08 | | 識別子（ID）: | (2~{R})-2-azanyl-3-[(2~{S},3~{R})-2-methyl-5-oxidanylidene-pyrrolidin-3-yl]sulfanyl-propanal |
|
